PhRMA pres warns against DTC moratorium

Share this article:
In a statement warning the Senate against imposing a moratorium on DTC, PhRMA president and CEO Billy Tauzin said: “DTC empowers patients by increasing their awareness of diseases and available treatments. Banning this information— even for just a couple of years—is not in the best interest of patients and physicians who every day make important healthcare decisions.”

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Judge blocks FDA bid to allow generic Precedex

Judge blocks FDA bid to allow generic Precedex

The US District Court for Maryland granted Hospira a temporary restraining order (TRO) against FDA, after the agency determined that potential generic competitors of the company's injectable sedation drug Precedex ...

GSK drug gets aplastic anemia indication

GSK drug gets aplastic anemia indication

Promacta was previously indicated for chronic immune thrombocytopenia.

Five things for Pharma Marketers to know: Wednesday, August 27

Five things for Pharma Marketers to know: Wednesday, ...

Allergan sets a shareholder voting date, Novo describes the types of acquisitions it will consider, and the AstraZeneca-Pfizer talks can now reopen.